Informa Life Sciences' Medical Device Regulatory Affairs in Emerging Markets conference offers detailed regulatory updates, practical insight and the opportunity to share experiences from market approval applications in Russia, CIS, Asia Pacific, Turkey and MENA. Industry leaders come together to explore and interpret the regulatory expectations and to share best practice for successful product registration in key regions, preparing delegates for compliance in emerging markets. Taking place in Berlin in June, the event offers two interactive evening seminars and excellent networking opportunities.
Interactive evening seminars:
Success Strategies for Conducting a Clinical Trial in Russia
Wednesday 23 June 2015
Led by: Anna Harrington Morozova, Scientific & Regulatory Director, Regem Consulting, UK
Culture and Communication Consideration (CCC) in China
Wednesday 24 June 2015
Led by: Lian Zhang Ph.D., Senior Regulatory Affairs Expert, HemoCue AB Sweden
Conference highlights include:
- Latest regulatory updates and practical considerations for product registration in Russia
- Carrying out clinical studies whilst adhering to CFDA requirements
- Assess the current status of AMDD implementation across the ASEAN region
- Status of the Pharmaceutical and Medical Devices Law (PMDL)
- Examine the IMDRF Medical Device Single Audit Programme
- An overview of the regulatory requirements for successful product registration in Mexico
- Gain clarification on the Customs Union - Russia, Belarus, Kazakhstan and Armenia
Please visit http://www.informa-ls.com/CQ5261MedDevRAEM for more information.